Modern clinical research on LSD

Liechti, Matthias E·2017·Neuropsychopharmacology
DOI 10.1038/npp.2017.86

Cited by (236)

Items 201–236 of 236

  1. Consumo de sustancias ilícitas en jóvenes y sus alteraciones en el sistema nervioso.
    Karolayn Nicolle Pérez Rodriguez, Alexander Darío Castro Jalca, Antonella Roxana Pillasagua Mero, José Omar Ordoñez Loor · 2023 · Revista Científica Higía de la Salud
  2. Toksik Maddelerin Sınıflandırılması
    Merve Kuloğlu Genç, Tuğba Tekin Bülbül, Sümeyye Zülal Şimşek, Zeynep Arslan, Simge Zengin, Zeynep Türkmen · 2023
  3. Adli Toksikolojinin Tanımı ve Tarihsel Gelişimi
    Münevver Açıkkol · 2023
  4. Adli Toksikolojide Yasal Uygulamalar ve Raporlama
    Münevver Açıkkol · 2023
  5. Adli Toksikoloji Laboratuvarı ve Yöntem Geçerliliği
    Tuğba Tekin Bülbül, Murat Yayla, Selda Mercan · 2023
  6. Zehirlenmelere Adli ve Klinik Yaklaşım
    Işıl Bavunoğlu · 2023
  7. Toksikolojide Temel Kavramlar
    Selda Mercan, Simge Zengin · 2023
  8. Adli Toksikolojide Kullanılan Deliller ve Numune Hazırlama Yöntemleri
    Simge Zengin, Merve Kuloglu, Zeynep TÜRKMEN, Selda Mercan · 2023
  9. Adli Toksikolojide Yenilikçi Yaklaşımlar
    Sümeyye Zülal Şimşek, Merve Kuloglu, Selda Mercan · 2023
  10. Appropriate Drugs
    Emma Eleonorasdotter · 2023 · Springer eBooks
  11. Evaluation of spontaneous exploratory and anxiety-related behaviors of mice treated with gymnopilins obtained from the mushroom Gymnopilus imperialis (Agaricomycetes, Basidiomycota)
    Lhaís Araújo Caldas, Beatriz Gangale Muratori, Andressa Gabriela Soliani, Suzete Maria Cerutti, Patrı́cia Sartorelli · 2024 · Toxicon
  12. From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine
    Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi Chiedozie Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius Ituma Azi, Joseph Anderson et al. · 2024 · European Journal of Arts Humanities and Social Sciences
  13. Le LSD, entre scène artistique et traitement des troubles anxio-dépressifs
    Linda Amrouche · 2024 · Actualités Pharmaceutiques
  14. Psychédéliques et psychédélisme, tour d’horizon
    Linda Amrouche · 2024 · Actualités Pharmaceutiques
  15. Enlightenment
    Colin Feltham · 2024 · Springer eBooks
  16. Microdosing Psychedelics as a Promising New Pharmacotherapeutic
    Kim P. C. Kuypers · 2024 · Springer eBooks
  17. Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new
    Mansi Dave, Ron Shore, Tracy Cupido, Chris Haley, David Clinkard · 2025 · European Journal of Anaesthesiology
  18. Ellagic acid mitigates LSD-induced neurobehavioral disorders via pro-inflammatory pathway inhibition in Wistar rats
    Saiedeh Arabmoazzen, Mohammad Ali Mirshekar, Kimia KHaleghpoor, Mohsen Abedini Esfahlani, Fereshteh Badini · 2025 · Neuroscience and Behavioral Physiology
  19. LSD
    Zachary I. Lerner, Joy C. Liu, Paul D. Thielking, David Luce · 2025
  20. Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder
    Laurie Cazorla, Sylvie Alaux, Caroline Amberger, Cédric Mabilais, Leonice Furtado, Albert Buchard, Gabriel Thorens, Louise E. Penzenstadler, DANIELE FABIO ZULLINO, Tatiana Aboulafia Brakha · 2025 · Psychoactives
  21. “It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics
    Blake Beaton · 2025 · Journal of Drug Issues
  22. Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics
    Lingyu Zhang, Weiyang Shi, Ziyang Zhao, Zhichao Wang, Congying Chu, Bokai Zhao, Jiaqi Zhang, Qianhui Liu, Yueheng Lan, Tianzi Jiang · 2025 · PLoS Computational Biology
  23. Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study
    Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli et al. · 2025 · Psychology International
  24. Linking Substance Use and Schizophrenia
    Emre Mutlu, Hayri Can Özden, Aygün Ertuğrul · 2025 · Springer eBooks
  25. THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska · 2026 · International Journal of Innovative Technologies in Social Science
  26. Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review
    James Chmiel, Filip Rybakowski · 2026 · International Journal of Molecular Sciences
  27. Emotion dysregulation in autistic adults : an ecological, self-report, and physiological approach
    Mădălina Elena Costache · 2024 · theses.fr (ABES)
  28. Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects
    Zhen Xuen Brandon Low · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  29. "Riding the Wave"—Social Work Roles in Psychedelic Therapy Settings: A Scoping Review
    Abel Walker, Stacey R. Kolomer, Kristin W. Mapson · 2026 · Clinical Social Work Journal
  30. New psychoactive substances (designer drugs): an approach to classification
    Azat R. Asadullin, E. A. Akhmetova, Ефремов Илья Сергеевич, Mars A. Sary, Artem S. Shkolyar, Гасенко Ксения Александровна, Evgeny M. Krupitsky · 2026 · Neurology Bulletin
  31. Consommation illicite de psychédéliques classiques et suicidalité : une revue systématique de la littérature
    Ana Beatriz Pereira de Oliveira, Matthieu Hein · 2026 · L Encéphale
  32. Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression
    Lucca Jaeckel, Deborah Logvinski, Mika Kanana, Felix Müller, Nicolai Rohner, Anna M. Becker, Matthias E. Liechti, Philipp Sterzer · 2026 · Neuroscience of Consciousness
  33. Synesthesia and associated clinical conditions: A comprehensive review of current evidence
    Zahra Rahimian, Soodeh Jahangiri, Seyed Reza Abdipour Mehrian, Mohammadreza Akbari, Seyedarad Mosalamiaghili, Zahra Ghahramani, Zahra Eghlidos, Arezoo Behbood · 2026 · Heliyon
  34. Ethics of psychedelics in clinical research: a state-of-the-field review
    Katherine Cheung, Edward Jacobs, David B. Yaden · 2026 · JME Practical Bioethics
  35. DT120 (MM120): a single-dose orally disintegrating formulation of lysergide tartrate for generalized anxiety disorder
    Wiesław Jerzy Cubała · 2026 · Expert Review of Neurotherapeutics
  36. BindingDB Entry 50021858: The role of the methoxy group in approved drugs.
    BindingDB · 2025 · UC San Diego